Trial Profile
A Multicenter, Randomized, Double-blind Phase III Study of Mometasone Furoate/Azelastine Hydrochloride Combination Group and Mometasone Furoate and Azelastine Hydrochloride Group 4 Weeks After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Perennial Allergic Rhinitis Patient.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Aug 2013
Price :
$35
*
At a glance
- Drugs Azelastine/mometasone (Primary) ; Azelastine; Mometasone
- Indications Perennial allergic rhinitis
- Focus Therapeutic Use
- Sponsors Hanlim Pharmaceutical
- 15 Nov 2011 New trial record